CUE — Cue Biopharma Cashflow Statement
0.000.00%
Last trade - 00:00- $59.16m
- $41.03m
- $9.29m
Annual cashflow statement for Cue Biopharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -44.8 | -44.2 | -53 | -50.7 | -40.7 |
| Depreciation | |||||
| Non-Cash Items | 10 | 8.56 | 9.53 | 11.6 | 8.97 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 1.24 | -4.49 | 0.751 | -1.36 | -5.02 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -32.5 | -38.8 | -41.8 | -40 | -36.3 |
| Capital Expenditures | -0.595 | -0.913 | -0.171 | 0 | -0.066 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 5.05 | 10 | -24.4 | 25 | 0.098 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | 4.46 | 9.11 | -24.6 | 25 | 0.032 |
| Financing Cash Flow Items | 0 | 0 | -0.142 | 0 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 58.6 | 19.2 | 53.7 | 11.9 | 10.2 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 30.6 | -10.5 | -12.8 | -3.1 | -26.1 |